| |
Metformin + SGLT-2i (n = 34)
|
Other GLD (n = 34)
|
p value
| |
|
In-hospital deaths
|
6 (17.6%)
|
10 (29.4%)
|
0.391
|
1.000
|
|
ICU admission, mechanical ventilation, or in-hospital death
|
10 (29.4%)
|
11 (32.4%)
|
0.987
|
0.965
|
|
In-hospital complications
|
19 (55.9%)
|
22 (64.7%)
|
0.620
|
0.201
|
|
Long-time hospital stay
|
6 (17.6%)
|
4 (11.8%)
|
0.732
|
0.838
|
| |
Metformin + insulin (n = 67)
|
Other GLD (n = 67)
|
p value
| |
|
In-hospital deaths
|
24 (35.8%)
|
23 (34.3%)
|
1.000
|
0.521
|
|
ICU admission, mechanical ventilation, or in-hospital death
|
46 (68.7%)
|
36 (53.7%)
|
0.112
|
0.111
|
|
In-hospital complications
|
44 (65.7%)
|
36 (53.7%)
|
0.218
|
0.480
|
|
Long-time hospital stay
|
15 (22.4%)
|
13 (19.4%)
|
0.832
|
0.870
|
